Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Orexigen Therapeutics (NASDAQ:OREX): The shares closed at $2.19, up $0.27, or 14.06%, on the day. Its market capitalization is $105.31 million. About the company: Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.
  • Insmed Incorporated (NASDAQ:INSMD): The shares closed at $4.71, up $0.41, or 9.53%, on the day. Its market capitalization is $116.96 million. About the company: Insmed Incorporated is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.
  • Alphatec Holdings, Inc. (NASDAQ:ATEC): The shares closed at $2.23, up $0.18, or 8.78%, on the day. Its market capitalization is $198.97 million. About the company: Alphatec Holdings, Inc. manufactures medical devices. The Company produces products for the surgical treatment of spinal disorders. Alphatec manufactures spine screws, spinal spacers, and plates.
  • Brookdale Senior Living (NYSE:BKD): The shares closed at $12.86, up $1.03, or 8.71%, on the day. Its market capitalization is $1.57 billion. About the company: Brookdale Senior Living Inc. operates senior living facilities in the United States. The Company offers its residents access to a full continuum of services across all sectors of the senior living industry. Brookdale Senior operates independent living facilities, assisted living facilities, continuing care retirement communities, and a skilled nursing facility.
  • Array BioPharma Inc. (NASDAQ:ARRY): The shares closed at $2.13, up $0.16, or 8.12%, on the day. Its market capitalization is $121.45 million. About the company: Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

Losers (% price change)

  • Cornerstone Therapeutics (NASDAQ:CRTX): The shares closed at $6.26, down $0.79, or 11.21%, on the day. Its market capitalization is $162.48 million. About the company: Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body’s inflammatory response associated with asthma and critical care diseases, and products for the respiratory market.
  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $5.49, down $0.43, or 7.31%, on the day. Its market capitalization is $138.62 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data.
  • Palomar Medical Tech (NASDAQ:PMTI): The shares closed at $7.94, down $0.52, or 6.15%, on the day. Its market capitalization is $151.10 million. About the company: Palomar Medical Technologies, Inc. develops and supplies proprietary laser systems for hair removal and other cosmetic laser treatments. The Company’s systems are installed in physician offices worldwide.
  • Cadence Pharmaceuticals (NASDAQ:CADX): The shares closed at $6.52, down $0.42, or 6.05%, on the day. Its market capitalization is $414.77 million. About the company: Cadence Pharmaceuticals Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections.
  • MannKind Corporation (NASDAQ:MNKD): The shares closed at $3.49, down $0.21, or 5.68%, on the day. Its market capitalization is $457.08 million. About the company: MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet